Status:
UNKNOWN
Endocervical Lidocaine Spray for Pain Control During Office Hysteroscopy
Lead Sponsor:
Kasr El Aini Hospital
Conditions:
Pain Uterus
Eligibility:
FEMALE
20-45 years
Phase:
PHASE2
PHASE3
Brief Summary
lidocaine spray is used endocervical before office hysteroscopy to reduce the pain
Detailed Description
5 sprays of Lidocaine is applied 3 minutes before office hysteroscopy
Eligibility Criteria
Inclusion
- Patients indicated for diagnostic hysteroscopy for infertility or AUB. Postmenstrual between days 7 and 11 of the cycle ( except in irregular bleeding)
Exclusion
- Contraindication to office hysteroscopy Neurological disorders affecting the evaluation of pain. Previous cervical surgery.
Key Trial Info
Start Date :
December 20 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2018
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT03382743
Start Date
December 20 2017
End Date
March 1 2018
Last Update
January 24 2018
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Kasr El Ainiy Hospital
Cairo, Egypt, 11562
2
Kasr Alaini hospital
Cairo, Egypt